Source: Guideline 2003



Rating:

Share or cite this content

Citations should be made in the following way:
ATS Board of Directors, December 2002, and by the ERS Executive Committee, February 2003. ATS / ERS: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin Deficiency. Guideline 2003

Member's Comments

No comment yet.

Related content which might interest you: GPs Meet Rare Lung Disorders Task Force factsheet: alpha-1 antitrypsin deficiency Source: Breathe 2014; 10: 87-89 Year: 2014 ATS / ERS: International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias Source: Guideline 2002 Year: 2002 International ERS/ATS Guidelines on Definition, Evaluation and Treatment of Severe Asthma Source: Guideline 2014 Year: 2014 Severe Pulmonary Hypertension Management Across Europe (PHAROS): an ERS Clinical Research Collaboration Source: Eur Respir J, 55 (5) 2001047; 10.1183/13993003.01047-2020 Year: 2020 Late Breaking Abstract - Characteristics of Patients Diagnosed with Severe Asthma at UK Specialist Centres: Variation by Ethnicity Source: International Congress 2019 – Bronchiectasis Year: 2019 An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management Source: Guideline 2011 Year: 2011 Evaluation of COPD Patient’s Relatives Assessment of Disease Awarness, Load of Care Giving and Loss of Workforce: Turkish Thoracic Society COPD Working Group. Source: International Congress 2018 – Patient-reported outcomes and scores in COPD Year: 2018 Members of the Task Force on Recognizing and Diagnosing Exercise-Related Asthma, Respiratory and Allergic Disorders in Sports Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-22-7, page=105 Year: 2005 Postinfectious Bronchiolitis Obliterans in Children - Diagnostic Workup and Therapeutic Options - A Workshop Report Source: Virtual Congress 2020 - Pre-reading material Year: 2020 Immunogenicity of Mepolizumab in Patients with Severe Eosinophilic Asthma: Experience from the Clinical Development Program Source: International Congress 2018 – Novel immunology-based therapies in asthma and COPD Year: 2018 Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Source: Guideline 2018 Year: 2018 Impact on Adherence to the 2012 Evaluation and Management of Pediatric Community Acquired Pneumonia Philippine Academy of Pediatric Pulmonologist (PAPP) Update Source: International Congress 2018 – Clinical problems in paediatric pulmonology Year: 2018 Assessment of Severe Asthma Management Practices among Pulmonologists and Allergists Source: International Congress 2018 – Medical education via the web and the internet Year: 2018 Allergy Testing in Asthmatics and Severe Asthmatics in Belgium : Role of Comorbidities Source: Virtual Congress 2020 – Asthma management: role of biomarkers and comorbidities Year: 2020 What Can Be Expected From Pathology Assessment? Or: Is Severe Asthma Still an Eosinophilic Disease? Source: Research Seminar 2007 - Severe Asthma Year: 2007 Effectiveness of Pulmonary Rehabilitation for Patients with Asthma: EPRA-RCT Source: International Congress 2018 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2018 Chronic Airway Diseases Early Stratification (CADSET): a new ERS Clinical Research Collaboration Source: Eur Respir J, 53 (3) 1900217; 10.1183/13993003.00217-2019 Year: 2019 Late Breaking Abstract - Real-World Characteristics of Patients Receiving Dupilumab in Routine Clinical Practice in a Multinational, Non-Interventional Study (ProVENT) Source: Virtual Congress 2021 – Airway pharmacology: translational and basic science Year: 2021 2016 China Guideline of Asthma Diagnosis and Management Source: International Congress 2016 – China Session I Year: 2016 Effects of Thoracic Mobilization Techniques on Pulmonary Functions, Dyspnea and Health Status in Patients with Asthma Source: International Congress 2019 – Role of the physiotherapist for patients with lung disease Year: 2019